AC
FMTX

Athanor Capital’s Forma Therapeutics Holdings, Inc. Common Stock FMTX Stock Holding History

Athanor Capital’s Portfolio FMTX Stock Details FMTX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q2 		– Sell
-17,170
Closed -$481K – 946
2021
Q1 		$481K Sell
17,170
-26,822
-61% -$968K 0.01% 489
2020
Q4 		$1.53M Buy
43,992
+15,005
+52% +$653K 0.03% 235
2020
Q3 		$1.45M Buy
+28,987
New +$1.17M 0.06% 180

Other funds holding FMTX

RCM
RA Capital Management Boston, Massachusetts $9.44B AUM 157.3% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
CAM
Cormorant Asset Management Boston, Massachusetts $1.99B AUM 737.95% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
BBA
Baker Bros. Advisors New York $17.4B AUM 131.5% 1-Year Est. Return
SB
Samsara BioCapital Palo Alto, California $1.03B AUM 214.94% 1-Year Est. Return
LGM
Logos Global Management San Francisco, California $2B AUM 444.09% 1-Year Est. Return
HA
HHLR Advisors Grand Cayman, Cayman Islands $1.67B AUM 7.53% 1-Year Est. Return

Athanor Capital's FMTX Position: Q2 2021 in Review

Athanor Capital sold out of Forma Therapeutics Holdings, Inc. Common Stock (FMTX) in Q2 2021, closing a stake of 17,170 shares — an estimated $481K sold.

Athanor Capital first reported a position in FMTX in Q3 2020 and held it in 3 quarters. The position peaked at $1.53M in Q4 2020. 82 funds tracked by Wall St. Rank hold FMTX as of Q2 2021.

  • Athanor Capital reported no remaining Forma Therapeutics Holdings, Inc. Common Stock position as of Q2 2021 after selling out during the quarter.
  • Athanor Capital sold 17,170 Forma Therapeutics Holdings, Inc. Common Stock shares in Q2 2021, an estimated $481K.
  • Athanor Capital first reported a position in Forma Therapeutics Holdings, Inc. Common Stock in Q3 2020 and held it in 3 quarters.
  • Athanor Capital's Forma Therapeutics Holdings, Inc. Common Stock position peaked at $1.53M in Q4 2020.
  • 82 funds tracked by Wall St. Rank held Forma Therapeutics Holdings, Inc. Common Stock as of Q2 2021.

Based on Athanor Capital's 13F filing for Q2 2021, filed 16 Aug 2021.